NCT03829046
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- St. Michael's - University of Toronto Toronto, Ontario, Canada
Clinical trial condition
Atherosclerotic Vascular Disease
Explore clinical trials studying Atherosclerotic Vascular Disease. Study availability and eligibility vary by location and protocol.
5 public trials
0 recruiting studies
Atherosclerotic Vascular Disease trial results
NCT02162303
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
- Locations
-
- Montreal Heart Institute Montreal, Quebec, Canada
NCT00703261
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
- Locations
-
Not specified
Active, Not Recruiting
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
NCT06958315
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more
- Locations
-
- Novartis Investigative Site Cadiz, Andalusia, Spain
- Novartis Investigative Site Granada, Andalusia, Spain
- Novartis Investigative Site Huelva, Andalusia, Spain
- Novartis Investigative Site Jaén, Andalusia, Spain
Active, Not Recruiting
Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events
NCT06855394
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
- Locations
-
- UF Health Gainesville, Florida, United States
- UF Health Jacksonville, Florida, United States